• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫内和分娩期人类免疫缺陷病毒传播的不同危险因素以及对受感染儿童疾病进展的影响。围产期艾滋病协作传播研究。

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study.

作者信息

Kuhn L, Steketee R W, Weedon J, Abrams E J, Lambert G, Bamji M, Schoenbaum E, Farley J, Nesheim S R, Palumbo P, Simonds R J, Thea D M

机构信息

Columbia University, Medical and Health Research Association Inc., Harlem Hospital Center, New York, USA.

出版信息

J Infect Dis. 1999 Jan;179(1):52-8. doi: 10.1086/314551.

DOI:10.1086/314551
PMID:9841822
Abstract

Predictors and prognosis of intrauterine and intrapartum human immunodeficiency virus (HIV) transmission were investigated among 432 children of HIV-infected women in the Perinatal AIDS Collaborative Transmission Study. Timing of transmission was inferred from polymerase chain reaction or viral culture within 2 days of birth. Proportions of infections due to intrauterine transmission were similar among women using (29%) or not using zidovudine (30%). Preterm delivery was strongly associated with intrapartum transmission (relative risk, 3.7; 95% confidence interval [CI], 2.2-6.1), particularly among infants delivered longer after membrane rupture, but was not associated with intrauterine transmission. Progression to AIDS or death increased 2.5-fold (95% CI, 1.1-5.8) among intrauterine infected children, adjusting for preterm delivery, and maternal CD4 cell count. Early transmission appears unlikely to explain instances of zidovudine failure. Preterm infants may be more vulnerable to HIV acquisition at delivery, especially if membrane rupture is prolonged. Intrauterine infection does not appear to increase risk of preterm delivery.

摘要

在围产期艾滋病协作传播研究中,对432名感染人类免疫缺陷病毒(HIV)的女性所生子女进行了宫内和产时HIV传播的预测因素及预后研究。传播时间根据出生后2天内的聚合酶链反应或病毒培养结果推断。使用齐多夫定的女性(29%)和未使用齐多夫定的女性(30%)中,因宫内传播导致感染的比例相似。早产与产时传播密切相关(相对风险为3.7;95%置信区间[CI]为2.2 - 6.1),尤其是在胎膜破裂后较长时间分娩的婴儿中,但与宫内传播无关。在调整早产和母亲CD4细胞计数后,宫内感染儿童进展为艾滋病或死亡的风险增加了2.5倍(95%CI为1.1 - 5.8)。早期传播似乎无法解释齐多夫定治疗失败的情况。早产儿在分娩时可能更容易感染HIV,尤其是胎膜破裂时间延长时。宫内感染似乎不会增加早产风险。

相似文献

1
Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study.宫内和分娩期人类免疫缺陷病毒传播的不同危险因素以及对受感染儿童疾病进展的影响。围产期艾滋病协作传播研究。
J Infect Dis. 1999 Jan;179(1):52-8. doi: 10.1086/314551.
2
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.接受齐多夫定治疗的女性中人类免疫缺陷病毒1型围产期传播的危险因素。儿童艾滋病临床试验组研究185团队。
N Engl J Med. 1999 Aug 5;341(6):385-93. doi: 10.1056/NEJM199908053410601.
3
Timing of maternal-infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group.母婴HIV传播的时机:分娩期因素与早期聚合酶链反应结果之间的关联。纽约市围产期HIV传播协作研究组。
AIDS. 1997 Mar 15;11(4):429-35. doi: 10.1097/00002030-199704000-00005.
4
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.齐多夫定治疗降低母婴1型人类免疫缺陷病毒传播。儿童艾滋病临床试验组方案076研究小组。
N Engl J Med. 1994 Nov 3;331(18):1173-80. doi: 10.1056/NEJM199411033311801.
5
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.母亲的病毒载量、齐多夫定治疗与人类免疫缺陷病毒1型母婴传播风险。儿童艾滋病临床试验组方案076研究小组。
N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201.
6
After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.艾滋病临床试验076之后:齐多夫定在孕期的使用模式变化,以及随后一组感染艾滋病毒的妇女及其婴儿中人类免疫缺陷病毒垂直传播率的降低。妇女与婴儿传播研究小组。
J Infect Dis. 1996 Dec;174(6):1207-11. doi: 10.1093/infdis/174.6.1207.
7
Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.对332名有HIV-1感染风险的婴儿自出生起进行前瞻性监测,分析其感染状况和早期死亡的新生儿预测因素。纽约市围产期HIV传播协作研究小组。
Pediatrics. 1995 Sep;96(3 Pt 1):451-8.
8
Preventing perinatal HIV transmission: zidovudine use during pregnancy.预防围产期HIV传播:孕期使用齐多夫定。
Am Fam Physician. 1997 Jan;55(1):171-4, 177-8.
9
Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.产前齐多夫定对围产期感染HIV-1婴儿疾病进展的影响。
J Acquir Immune Defic Syndr. 2000 Jun 1;24(2):154-61. doi: 10.1097/00126334-200006010-00010.
10
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.确定与围产期传播风险相关的孕产妇HIV-1 RNA水平。孕产妇齐多夫定治疗对病毒载量的影响。
JAMA. 1996 Feb 28;275(8):599-605.

引用本文的文献

1
Adverse Perinatal Outcomes among Adolescent Pregnant Women Living with HIV: A Propensity-Score-Matched Study.青少年 HIV 感染者孕妇的不良围产结局:一项倾向评分匹配研究。
Int J Environ Res Public Health. 2023 Apr 10;20(8):5447. doi: 10.3390/ijerph20085447.
2
Peripartum HIV infection in very low birth weight infants fed 'raw' mother's own milk.极低出生体重儿喂养“未经处理”的母乳时的围产期HIV感染
South Afr J HIV Med. 2019 Jun 19;20(1):912. doi: 10.4102/sajhivmed.v20i1.912. eCollection 2019.
3
Association between maternal HIV disclosure and risk factors for perinatal transmission.
母婴 HIV 披露与围产期传播危险因素的关联。
J Perinatol. 2018 Jun;38(6):639-644. doi: 10.1038/s41372-018-0066-2. Epub 2018 Feb 12.
4
Getting to 90-90-90 in paediatric HIV: What is needed?实现儿科艾滋病治疗的90-90-90目标:需要什么?
J Int AIDS Soc. 2015 Dec 2;18(7Suppl 6):20770. doi: 10.7448/IAS.18.7.20770. eCollection 2015.
5
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.最后的也是首要的前沿领域——生命第一周艾滋病毒治疗与预防面临的新挑战,重点关注早产儿和低体重儿。
J Int AIDS Soc. 2015 Dec 2;18(Suppl 6):20271. doi: 10.7448/IAS.18.7.20271. eCollection 2015.
6
Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.子宫内和分娩时传播的建模,以评估预防围产期艾滋病毒干预措施的效果。
PLoS One. 2015 May 19;10(5):e0126647. doi: 10.1371/journal.pone.0126647. eCollection 2015.
7
The role of co-infections in mother-to-child transmission of HIV.合并感染在HIV母婴传播中的作用。
Curr HIV Res. 2013 Jan;11(1):10-23. doi: 10.2174/1570162x11311010003.
8
Pregnancy loss and role of infant HIV status on perinatal mortality among HIV-infected women.妊娠丢失和婴儿 HIV 状态对感染 HIV 的女性围产儿死亡率的影响。
BMC Pediatr. 2012 Aug 31;12:138. doi: 10.1186/1471-2431-12-138.
9
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.孕期抗逆转录病毒治疗不足:欧洲预防母婴传播艾滋病毒的错失机遇
Antivir Ther. 2011;16(6):895-903. doi: 10.3851/IMP1849.
10
Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.产前 HIV-1 RNA 载量与母婴传播时间:资源匮乏环境下的巢式病例对照研究。
Virol J. 2010 Aug 2;7:176. doi: 10.1186/1743-422X-7-176.